How does Clopidogrel compare to newer antiplatelet agents in managing high-risk thrombotic events, and what are the benefits of switching therapies?
Sahil KapoorExplorer
How does Clopidogrel compare to newer antiplatelet agents in managing high-risk thrombotic events?
Share
Clopidogrel is less effective at preventing recurrent events compared to newer agents like ticagrelor, which offers faster, more potent antiplatelet action.